- 全部删除
- 您的购物车当前为空
Atoltivimab (REGN3470) 与 maftivimab/odesivimab (Inmazeb),是美国食品和活性分子管理局 (FDA) 批准的针对扎伊尔埃博拉病毒 (EBOV) 感染的单克隆抗体。
Atoltivimab (REGN3470) 与 maftivimab/odesivimab (Inmazeb),是美国食品和活性分子管理局 (FDA) 批准的针对扎伊尔埃博拉病毒 (EBOV) 感染的单克隆抗体。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 2,490 | 2-4周 | |
5 mg | ¥ 6,470 | 2-4周 | |
10 mg | ¥ 9,870 | 2-4周 |
Atoltivimab 相关产品
产品描述 | Atoltivimab (REGN3470), also known as maftivimab/odesivimab (Inmazeb), represents the first monoclonal antibody approved by the Food and Drug Administration (FDA) to combat Zaire ebolavirus (EBOV) infection [1]. |
CAS No. | 2135632-29-8 |
存储 | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容